diabetic ketoacidosis

Search with Google Search with Bing
Information
Disease name
diabetic ketoacidosis
Disease ID
DOID:1837
Description
"A metabolic acidosis that is characterized by the shift of acid-base status of the body toward the acid side accompanied by the accumulation of ketone bodies in body tissues and fluids, resulting from uncontrolled diabetes mellitus." [url:https\://medlineplus.gov/ency/article/000320.htm, url:https\://www.mayoclinic.org/diseases-conditions/diabetic-ketoacidosis/symptoms-causes/syc-20371551]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02443415 Completed Diabetic Ketoacidosis: Brain Morphology and Cognition February 2015 October 1, 2017
NCT00426413 Completed Ketosis Prone Diabetes in African-Americans May 2007 August 2010
NCT00589680 Completed Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis December 2007 July 2008
NCT00590044 Completed Phase 4 Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA) December 2007 August 2008
NCT00629707 Completed N/A Cerebral Edema in Pediatric Diabetic Ketoacidosis June 2008 June 2011
NCT00920725 Completed N/A Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA January 2005 December 2007
NCT01365793 Completed Phase 3 Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis November 2010 January 2017
NCT01753921 Completed Evaluation of a Non-invasive Brain Compliance Measurement Device November 2011 October 2016
NCT02006342 Completed N/A Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis November 2012 April 2013
NCT00179127 Completed N/A Use of Insulin Glargine to Treat Diabetic Ketoacidosis August 2004 September 2012
NCT02930044 Completed N/A Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis October 2016 November 1, 2021
NCT03107208 Completed Phase 4 Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes July 21, 2017 March 13, 2021
NCT03128229 Completed Diabetic Kidney Alarm (DKA) Study June 1, 2017 December 13, 2019
NCT03182569 Completed N/A Flexible Catheter for Insulin in Diabetes December 11, 2016 April 9, 2018
NCT03660189 Completed N/A Two Bag System for Diabetic Ketoacidosis September 17, 2018 June 15, 2023
NCT04017221 Completed Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes October 1, 2018 December 1, 2019
NCT04656236 Completed N/A Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls January 1, 2021 March 1, 2022
NCT04825639 Completed Identifying Risk Factors for Developing AKI in Sepsis March 15, 2021 March 31, 2022
NCT04926740 Completed N/A Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department October 12, 2021 December 7, 2022
NCT04940897 Completed N/A Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care October 25, 2021 February 23, 2023
NCT04977011 Completed N/A Effectiveness of Music Intervention on Anxiety and Physiological Responses in Critical Ill Patient January 2, 2019 July 30, 2019
NCT06251895 Completed Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus August 1, 2021 November 11, 2023
NCT06327737 Completed Diabetic Ketoacidosis Diagnosis and Management December 15, 2020 March 15, 2023
NCT06186245 Enrolling by invitation N/A Starvation in the Treatment of Diabetic Ketoacidosis December 27, 2023 December 2024
NCT05752279 Not yet recruiting Phase 3 Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis March 2024 June 2026
NCT05867797 Not yet recruiting Risk Factors and Outcomes of Acute Kidney Injury in Patients With Diabetic Ketoacidosis at Sohag University Hospital. May 20, 2023 November 20, 2024
NCT05649891 Not yet recruiting N/A Checklists Resuscitation Emergency Department September 2023 March 2024
NCT05666895 Not yet recruiting Role of CBC as a Prognostic Marker for DKA Patients January 1, 2023 July 1, 2024
NCT03717896 Recruiting Phase 2 Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis November 21, 2018 October 1, 2024
NCT05383404 Recruiting Clinical and Laboratory Parameters Associated With Different Degrees of Dehydration Among Children With Diabetic Ketoacidosis June 25, 2022 June 2023
NCT05402579 Recruiting Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk July 29, 2022 June 6, 2024
NCT05443802 Recruiting N/A Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications August 16, 2022 February 16, 2025
NCT04567225 Terminated Phase 4 Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management October 1, 2020 August 27, 2021
NCT02548494 Terminated N/A Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes November 2015 February 1, 2019
NCT02950181 Terminated N/A Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients July 29, 2014 January 1, 2019
NCT03066440 Terminated Phase 4 Double Blinded Randomized Control Trial of Types of IVF in Children With DKA September 1, 2018 March 18, 2024
NCT04234867 Terminated Phase 1 Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) May 18, 2022 August 26, 2022
NCT05155917 Unknown status Phase 2 Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care March 1, 2022 January 2024
NCT02130180 Unknown status DKA Optic Ultrasound April 2014 October 2015
NCT05439928 Unknown status N/A Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA) July 2022 July 2023
NCT04819178 Withdrawn Real Life Evaluation of SGLT2 Use in Type 1 Diabetes June 1, 2021 December 1, 2021
Disase is a (Disease Ontology)
DOID:0050758
Cross Reference ID (Disease Ontology)
ICD9CM:250.1
Cross Reference ID (Disease Ontology)
MESH:D016883
Cross Reference ID (Disease Ontology)
MIM:612227
Cross Reference ID (Disease Ontology)
NCI:C50530
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:154671004
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0011880
Exact Synonym (Disease Ontology)
DIABETES MELLITUS, KETOSIS-PRONE
Exact Synonym (Disease Ontology)
ketosis-prone diabetes mellitus
HPO alt_id (Human Phenotype Ontology)
HP:0008253
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0001953
MedGen concept unique identifier (MedGen Concept name)
C0011880
MedGen unique identifier (MedGen Concept name)
8351
MeSH unique ID (MeSH (Medical Subject Headings))
D016883